Eli Lilly seeks FDA approval for COVID-19 drug
Eli Lilly seeks FDA approval for COVID-19 drug
October 07, 2020
U.S. drugmaker Eli Lilly said is it seeking emergency use authorization from the FDA for its experimental COVID-19 antibody monotherapy and plans to pursue a similar approval for a combination therapy with two of its antibody drugs next month.
Post A Comment:
0 comments:
Leave a comment. Thanks!